Skip to main content
Erschienen in: Annals of Surgical Oncology 3/2010

01.10.2010 | American Society of Breast Surgeons

Use of Breast MRI Surveillance in Women at High Risk for Breast Cancer: A Single-Institutional Experience

verfasst von: Leisha Elmore, BS, Julie A. Margenthaler, MD

Erschienen in: Annals of Surgical Oncology | Sonderheft 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The study aim is to investigate indications for breast magnetic resonance imaging (MRI) screening for high-risk women and to determine outcomes, correlation with routine imaging, and adherence to current guidelines for use.

Methods

We identified 200 patients undergoing 275 breast MRIs for high-risk surveillance from 2005 to 2008. Data collected included patient characteristics, need for additional imaging and/or biopsy, correlation with routine imaging, and outcomes. Gail scores were calculated for patients without hereditary breast cancer syndromes or previous chest radiation. Descriptive statistics were utilized for data summary.

Results

Two hundred patients underwent 275 breast MRIs for high-risk surveillance (mean age 45 years, range 18–76 years). Indications included BRCA mutation (n = 21), history of chest radiation (n = 10), and perceived high risk (n = 169). The mean Gail score for the latter group was 25% (range 10–46%); 32 (16%) patients had Gail score <20%. Of 275 MRIs, 49 (18%) required additional imaging and 21 (8%) prompted biopsy. Of 21 biopsies, 4 were malignant; 2 were also visible on routine imaging performed concurrently with breast MRI. The false-positive rate for breast MRI screening in our cohort of high-risk patients was 23%.

Conclusion

The rate of cancer detection in high-risk patients undergoing breast MRI at our institution is similar to that of large, multicenter trials. Sixteen percent of patients undergoing breast MRI did not meet high-risk criteria. Because the need for additional imaging and biopsy remains high, further investigation is necessary to determine if this strategy is cost effective.
Literatur
1.
Zurück zum Zitat Ries L, Kosary C, Hankey B. SEER cancer statistics review, 1975–2000. USA National Cancer Institute 2003. Ries L, Kosary C, Hankey B. SEER cancer statistics review, 1975–2000. USA National Cancer Institute 2003.
2.
Zurück zum Zitat Kriege M, Brekelmans C, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427–37.CrossRefPubMed Kriege M, Brekelmans C, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427–37.CrossRefPubMed
3.
Zurück zum Zitat Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23:8469–76.CrossRefPubMed Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23:8469–76.CrossRefPubMed
4.
Zurück zum Zitat Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer. 2005;103:1898–905.CrossRefPubMed Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer. 2005;103:1898–905.CrossRefPubMed
5.
Zurück zum Zitat Stoutjesdijk MJ, Boetes C, Jager GJ, et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst. 2001;93:1095–102.CrossRefPubMed Stoutjesdijk MJ, Boetes C, Jager GJ, et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst. 2001;93:1095–102.CrossRefPubMed
6.
Zurück zum Zitat Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, clinical breast examination. JAMA. 2004;292:1317–25.CrossRefPubMed Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, clinical breast examination. JAMA. 2004;292:1317–25.CrossRefPubMed
7.
Zurück zum Zitat Kuhl CK, Schrading S, Wardelmann E, et al. Magnetic resonance imaging versus mammography for diagnosing ductal carcinoma in situ. J Clin Oncol. 2007;25:1504–10. Kuhl CK, Schrading S, Wardelmann E, et al. Magnetic resonance imaging versus mammography for diagnosing ductal carcinoma in situ. J Clin Oncol. 2007;25:1504–10.
8.
Zurück zum Zitat Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370:485–92.CrossRefPubMed Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370:485–92.CrossRefPubMed
9.
Zurück zum Zitat Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75–89.CrossRefPubMed Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75–89.CrossRefPubMed
10.
Zurück zum Zitat Carney P, Miglioretti D, Yankaskas B. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138:168–75.PubMed Carney P, Miglioretti D, Yankaskas B. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138:168–75.PubMed
11.
Zurück zum Zitat Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 2000;92:1081–7.CrossRefPubMed Mandelson MT, Oestreicher N, Porter PL, et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 2000;92:1081–7.CrossRefPubMed
12.
Zurück zum Zitat Rosenberg RD, Hunt WC, Williamson MR, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183, 134 screening mammograms in Albuquerque, New Mexico. Radiology. 1998;209:511–8.PubMed Rosenberg RD, Hunt WC, Williamson MR, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183, 134 screening mammograms in Albuquerque, New Mexico. Radiology. 1998;209:511–8.PubMed
13.
Zurück zum Zitat Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology. 1993;187:493–501.PubMed Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology. 1993;187:493–501.PubMed
14.
Zurück zum Zitat Hrung JM, Sonnad SS, Schwartz JS, Langlotz CP. Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Acad Radiol. 1999;6:387–97.CrossRefPubMed Hrung JM, Sonnad SS, Schwartz JS, Langlotz CP. Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Acad Radiol. 1999;6:387–97.CrossRefPubMed
15.
Zurück zum Zitat Peters NHGM, Rinkes IHMB, Zuithoff NPA, Mali WPTM, Moons KGM, Peeters PHM. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology. 2008;246:116–24.CrossRefPubMed Peters NHGM, Rinkes IHMB, Zuithoff NPA, Mali WPTM, Moons KGM, Peeters PHM. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology. 2008;246:116–24.CrossRefPubMed
16.
Zurück zum Zitat Gail M, Brinton L, Byar D, Corle D, Green S, Schairer C. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–86.CrossRefPubMed Gail M, Brinton L, Byar D, Corle D, Green S, Schairer C. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–86.CrossRefPubMed
17.
Zurück zum Zitat Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early onset breast cancer. Cancer. 1994;73:643–51.CrossRefPubMed Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early onset breast cancer. Cancer. 1994;73:643–51.CrossRefPubMed
18.
Zurück zum Zitat Miki Y, Swenson J, Shattuck-Eidens S, et al. A strong candidate gene for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71.CrossRefPubMed Miki Y, Swenson J, Shattuck-Eidens S, et al. A strong candidate gene for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71.CrossRefPubMed
19.
Zurück zum Zitat Euhus DM, Leitch AM, Huth JF, et al. Limitations of the Gail model in the specialized breast cancer risk assessment clinic. Breast J. 2002;8:23–27.CrossRefPubMed Euhus DM, Leitch AM, Huth JF, et al. Limitations of the Gail model in the specialized breast cancer risk assessment clinic. Breast J. 2002;8:23–27.CrossRefPubMed
20.
Zurück zum Zitat Hoskins KF, Zwaagstra A, Ranz M. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening. Cancer. 2006;107:1769–76.CrossRefPubMed Hoskins KF, Zwaagstra A, Ranz M. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening. Cancer. 2006;107:1769–76.CrossRefPubMed
21.
Zurück zum Zitat Taneja C, Edelsberg J, Weycker D, Guo A, Oster G, Weinreb J. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high risk women. J Am Coll Radiol. 2009;6:171.CrossRefPubMed Taneja C, Edelsberg J, Weycker D, Guo A, Oster G, Weinreb J. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high risk women. J Am Coll Radiol. 2009;6:171.CrossRefPubMed
Metadaten
Titel
Use of Breast MRI Surveillance in Women at High Risk for Breast Cancer: A Single-Institutional Experience
verfasst von
Leisha Elmore, BS
Julie A. Margenthaler, MD
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe Sonderheft 3/2010
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1236-4

Weitere Artikel der Sonderheft 3/2010

Annals of Surgical Oncology 3/2010 Zur Ausgabe

Editorial – American Society of Breast Surgeons

ASBrS and ASO: A New Partnership Begins

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.